IQVIA Holdings, Inc. (IQV) Earnings Call Analysis

NYSE · Healthcare · Diagnostics & Research

25/25

Growth 5 Margin 5 Expansion 5 Platform 5 Financial 5

latest quarter score

Earnings Reports

25
IQVIA (IQV) Q2 2026: R&D Bookings Surge 19%, Backlog Quality and AI Differentiation Drive Guidance Raise
July 28, 2026
22
IQVIA (IQV) Q4 2025: Backlog Climbs to $32.7B as AI-Driven Solutions Anchor Pharma Demand
June 15, 2026
25
IQVIA (IQV) Q1 2026: $34.2B Backlog Sets New High as AI-Driven Demand Accelerates Across Segments
May 05, 2026
19
IQVIA (IQV) Q3 2025: $2.6B Net Bookings Drive 13% Clinical Upswing, Margin Levers Shift to AI
October 28, 2025
18
IQVIA (IQV) Q2 2025: TAS Surges 8.9% as Backlog Hits $32B, AI Execution Accelerates
July 23, 2025
22
IQVIA (IQV) Q1 2025: TAS Growth Hits 7.6% as R&D Bookings Weather Macro Uncertainty
July 06, 2025

Browse all companies